Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study

Neuroscience
Nicoletta GaleottiCarla Ghelardini

Abstract

The importance of an intracellular calcium content increase to obtain cholinergic antinociception was demonstrated. The physiological and pathological role of ryanodine receptors (RyRs), receptors involved in the mobilization of intracellular calcium stores, at the CNS level is poorly understood. The aim of the present study was, therefore, to investigate the role of supraspinal endoplasmic type 1, 2 and 3 RyR subtypes in muscarinic antinociception in conditions of acute thermal (hotplate test) and inflammatory (abdominal constriction test) pain. In the absence of isoform selective RyR antagonists, types 1, 2 and 3 RyR knockdown mice were obtained. Western blotting experiments were performed to quantify the RyR isoform protein levels in knockdown mice demonstrating a selective protein level reduction in knockdown animals. I.c.v. pretreatment with an antisense oligonucleotide (aODN) against type 1 or type 3 RyR prevented cholinergic antinociception in the hotplate test shifting to the right of the physostigmine dose-response curve. This antagonistic effect disappeared 7 days after the end of the aODN administration. Conversely, the physostigmine analgesia remained unmodified in type 2 RyR knockdown mice. Similar results were obt...Continue Reading

References

Jan 1, 1992·British Journal of Pharmacology·A BartoliniA Giotti
Jan 1, 1996·Life Sciences·C GhelardiniF Gualtieri
Jun 1, 1997·Current Opinion in Neurobiology·K Mikoshiba
Aug 11, 1998·Neuron·M J Berridge
Feb 5, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·W ZhaoD L Alkon
Apr 26, 2000·British Journal of Pharmacology·C GhelardiniA Bartolini
Aug 4, 2001·Pflügers Archiv : European journal of physiology·S S SmailiA Jurkiewicz
Sep 25, 2002·Physiological Reviews·Michael Fill, Julio A Copello
Jan 25, 2003·Cell Calcium·Daniela Rossi, Vincenzo Sorrentino
May 9, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Nicoletta GaleottiCarla Ghelardini
Oct 1, 2003·Clinical and Experimental Pharmacology & Physiology·Angela F Dulhunty, Pierre Pouliquin
Jul 30, 2005·Behavioural Brain Research·Nicoletta GaleottiCarla Ghelardini

❮ Previous
Next ❯

Citations

Jul 12, 2014·Cell and Tissue Research·Anna M Hagenston, Manuela Simonetti
Jan 26, 2010·Biochemical Pharmacology·John J Mackrill
Feb 8, 2013·Endocrinology·Shu-Huei TsaiLee-Ming Chuang
Jul 29, 2021·Zygote : the Biology of Gametes and Early Embryos·G PercivaleG Prestipino

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.